Pharmabiz

China NMPA accepts Lynk Pharma’s NDA for zemprocitinib to treat moderate-to-severe atopic dermatitis

Lynk Pharmaceuticals Co., Ltd., a clinical-stage innovative drug development company, announced that the New Drug Application (NDA) for its core product, zemprocitinib capsules, for the treatment of ...
Pharmabiz

Telangana DCA intensifies statewide awareness campaign to combat drug misuse & promote safe medicine practices

Telangana DCA intensifies statewide awareness campaign to combat drug misuse & promote safe medicine practices: Our Bureau, Chennai Monday, April 13, 2026, 12:40 Hrs [IST] The Dru ...
Pharmabiz

IASO Bio inks partnership with Instituto Butantan to develop innovative therapy for haematological cancer

IASO Bio inks partnership with Instituto Butantan to develop innovative therapy for haematological cancer: Shanghai, Nanjing Monday, April 13, 2026, 12:00 Hrs [IST] IASO Biotechno ...
Pharmabiz

MetaVia begins patient dosing in Part 3 of phase 1 study of DA-1726, a GLP-1 and glucagon dual agonist to treat obesity

MetaVia begins patient dosing in Part 3 of phase 1 study of DA-1726, a GLP-1 and glucagon dual agonist to treat obesity: Cambridge, Massachusetts Monday, April 13, 2026, 11:00 Hrs ...
Pharmabiz

IPA CPD announces Regional Convention 2026 on May 17 in Goa to advance professionalism in pharmacy practice

IPA CPD announces Regional Convention 2026 on May 17 in Goa to advance professionalism in pharmacy practice: Our Bureau, Chennai Monday, April 13, 2026, 09:00 Hrs [IST] The Commun ...
Pharmabiz

UK MHRA approves Sobi’s olezarsen for the treatment of familial chylomicronemia syndrome

UK MHRA approves Sobi’s olezarsen for the treatment of familial chylomicronemia syndrome: United Kingdom Monday, April 13, 2026, 10:00 Hrs [IST] The Medicines and Healthcare pro ...
Pharmabiz

DCC recommends shifting of four drugs from Schedule H to H1 to bring them under tighter regulation

DCC recommends shifting of four drugs from Schedule H to H1 to bring them under tighter regulation: Gireesh Babu, New Delhi Monday, April 13, 2026, 08:00 Hrs [IST] The Drugs Consu ...
Pharmabiz

EFDA collaborates with Indian Pharma to meet Ethiopia’s regulatory requirements for faster drug approvals

EFDA collaborates with Indian Pharma to meet Ethiopia’s regulatory requirements for faster drug approvals: Shardul Nautiyal, Mumbai Monday, April 13, 2026, 08:00 Hrs [IST] The E ...
Pharmabiz

DCC forms sub-committee to look into feasibility of public disclosure of RBI details

DCC forms sub-committee to look into feasibility of public disclosure of RBI details: Gireesh Babu, New Delhi Monday, April 13, 2026, 08:00 Hrs [IST] The Drugs Consultative Commit ...
Pharmabiz

RDCA pushes for 'essential emergency service' status for pharma logistics

RDCA pushes for 'essential emergency service' status for pharma logistics: Peethaambaran Kunnathoor, Chennai Monday, April 13, 2026, 08:00 Hrs [IST] The Retail Distribution Chemis ...
Pharmabiz

Alexion to deliver 20 presentations across gMG, NF1 plexiform neurofibromas and neuromyelitis optica spectrum disorder at AAN meeting

Alexion to deliver 20 presentations across gMG, NF1 plexiform neurofibromas and neuromyelitis optica spectrum disorder at AAN meeting: Cambridge, UK Saturday, April 11, 2026, 18:0 ...
Pharmabiz

Sparian Biosciences begins phase 1 clinical trial of SBS-147; a next generation arylepoxamide receptor agonist to treat pain

Sparian Biosciences begins phase 1 clinical trial of SBS-147; a next generation arylepoxamide receptor agonist to treat pain: New York Saturday, April 11, 2026, 15:00 Hrs [IST] Sp ...